☆ 4.6 Article

Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell renal cell carcinoma

FRONTIERS IN ONCOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Oncology

Liver Metastases of Unknown Primary Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors: A Case Report and Literature Review

Davide Bimbatti et al.

Summary: This article presents a rare case of renal cell carcinoma (RCC) that initially presented with multiple liver and lymph node metastases but no primary renal lesion. The patient achieved an impressive response to treatment with a combination of immune checkpoint inhibitors and tyrosine kinase inhibitors. A multidisciplinary approach and diagnostic strategy are crucial for reaching a definitive diagnosis and selecting the appropriate treatment for mRCC without a primary tumor.

ANTICANCER RESEARCH (2023)

Add to Collection

Article Oncology

Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung Cancer

Lova Sun et al.

Summary: This study investigated the optimal duration of immune checkpoint inhibitor (ICI) treatment for patients with advanced non-small cell lung cancer (NSCLC) receiving frontline immunotherapy-based treatment. The results showed that there was no significant difference in overall survival between patients who continued ICI treatment beyond 2 years and those who received fixed-duration treatment for 2 years.

JAMA ONCOLOGY (2023)

Add to Collection

Article Oncology

Kidney Cancer, Version 3.2022

Robert J. Motzer et al.

Summary: The NCCN Guidelines for Kidney Cancer provide comprehensive treatment recommendations for renal cell carcinoma, covering screening, diagnosis, staging, surgery, and systemic therapy. Tumor histology and risk stratification of patients are important factors in treatment selection, considering efficacy, safety, evidence, and accessibility of agents.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)

Add to Collection

Review Cell Biology

Extrarenal renal cell carcinoma arising in the kidney proximity but without an identifiable renal primary - an intriguing dilemma: report of three cases and review of the literature

Mehdi Mansoor et al.

Summary: This article reports three cases of extrarenal renal cell carcinoma (RCC), highlighting its unusual clinical scenario. None of the patients had evidence of metastases or disease progression during diagnosis and follow-up. The article also reviews other similar reports, further supporting the existence of extrarenal RCC. The authors emphasize the need for awareness of this clinical scenario and suggest that establishing a correct diagnosis could aid in targeted therapy for selected cases.

HISTOPATHOLOGY (2022)

Add to Collection

Article Oncology

Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline

W. Kimryn Rathmell et al.

Summary: The article provides recommendations for the management of patients with metastatic clear cell renal cell carcinoma (ccRCC), including diagnosis, treatment, and participation in clinical trials.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Oncology

Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood

Jennifer Wilkinson Carlisle et al.

Summary: This study identifies potential immunological biomarkers that can predict therapeutic response in patients with advanced renal cell carcinoma (RCC). Assessing changes in T cells in the peripheral blood and tumor microenvironment, the researchers found that patients with the highest increase in specific activated T cells had the best antitumor immune response and clinical benefit.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Add to Collection

Review Oncology

Epidemiology and Prevention of Renal Cell Carcinoma

Tomoyuki Makino et al.

Summary: The incidence of renal cell carcinoma (RCC) is increasing globally, especially in developed countries. Advanced imaging and modifiable risk factors such as smoking, obesity, and hypertension contribute to the high rates. Primary prevention involves addressing risk factors, while secondary prevention focuses on early detection and biomarkers to reduce incidence and improve survival.

CANCERS (2022)

Add to Collection

Review Immunology

What is the optimal duration of immune checkpoint inhibitors in malignant tumors?

Jiaxin Yin et al.

Summary: Immunotherapy, specifically immune checkpoint inhibitors (ICIs), has significantly improved the treatment of malignant tumors and extended overall survival (OS). However, there is no clear consensus on the optimal duration of ICIs therapy in the medical community. Previous research suggests that the duration of ICIs therapy is related to immunotherapy response patterns, immune-related adverse events (irAEs), and tumor stages.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

T. K. Choueiri et al.

Summary: The study demonstrates that nivolumab plus cabozantinib has significant advantages over sunitinib in the treatment of previously untreated advanced renal-cell carcinoma, including progression-free survival, overall survival, and likelihood of response.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Robert Motzer et al.

Summary: The study demonstrated that the combination of lenvatinib with pembrolizumab led to significantly longer progression-free survival and overall survival than sunitinib, while the combination of lenvatinib with everolimus showed longer progression-free survival but not overall survival compared to sunitinib. Adverse events were more frequent in patients receiving lenvatinib-based treatments.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Oncology

Renal Cancer Without Primary Cancer in the Kidney: Extra-Renal TFE3 Translocation Associated Renal Cell Carcinoma

Benjamin Petrinec et al.

Summary: This case report describes an isolated para-aortic retroperitoneal renal cell carcinoma (RCC) without a primary kidney tumor, suggesting a rare form of translocation RCC. Immunohistochemistry showed positivity for TFE3 and TFEB, both associated with MiT translocation RCCs.

KIDNEY CANCER (2021)

Add to Collection

Article Urology & Nephrology

Primary extrarenal papillary renal cell carcinoma presenting as a neck mass

S. Srivishnu et al.

Summary: Extrarenal primary renal cell carcinoma is a rare entity with challenging clinical diagnosis. The final diagnosis in this case was confirmed by histopathological features and immunohistochemical markers.

INDIAN JOURNAL OF UROLOGY (2021)

Add to Collection

Article Anatomy & Morphology

Uncommon Localization of Extrarenal Xp11.2 Translocation-associated Renal Cell Carcinoma (RCC): Case Report

Jaudah Ahmed Al-Maghrabi et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2020)

Add to Collection

Review Surgery

A huge extrarenal cell carcinoma developing from a heterotopic renal anlage with distant metastases: case report and literature review

Omar AlShalabi et al.

JOURNAL OF SURGICAL CASE REPORTS (2020)

Add to Collection

Review Urology & Nephrology

Kidney Cancer An Overview of Current Therapeutic Approaches

Nivedita Chowdhury et al.

UROLOGIC CLINICS OF NORTH AMERICA (2020)

Add to Collection

Article Immunology

Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

Brian C. Miller et al.

NATURE IMMUNOLOGY (2019)

Add to Collection

Article Medicine, General & Internal

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Brian I. Rini et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Immunology

Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells

Sema Kurtulus et al.

IMMUNITY (2019)

Add to Collection

Article Immunology

Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy

Imran Siddiqui et al.

IMMUNITY (2019)

Add to Collection

Article Urology & Nephrology

Primary Extrarenal Type 2 Papillary Renal Cell Carcinoma: A Case Report

Youjian Li et al.

UROLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

An intra-tumoral niche maintains and differentiates stem-like CD8 T cells

Caroline S. Jansen et al.

NATURE (2019)

Add to Collection

Article Gastroenterology & Hepatology

Primary Extrarenal Renal Cell Carcinoma: A Unique Diagnosis Performed through Endoscopic Ultrasound

Goncalo Nunes et al.

GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY (2019)

Add to Collection

Review Pathology

Renal-type clear cell carcinoma of prostate: A case report and review of literature

Guangjie Liao et al.

INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2018)

Add to Collection

Article Medicine, General & Internal

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

R. J. Motzer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

Moshe Sade-Feldman et al.

CELL (2018)

Add to Collection

Article Medicine, General & Internal

Renal cell carcinoma

James J. Hsieh et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Add to Collection

Article Multidisciplinary Sciences

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

Se Jin Im et al.

NATURE (2016)

Add to Collection

Article Urology & Nephrology

Primary extra-renal clear cell renal cell carcinoma masquerading as an adrenal mass: A diagnostic challenge

Roumina Hasan et al.

UROLOGY ANNALS (2015)

Add to Collection

Letter Pathology

Extra-renal clear cell renal cell carcinoma probably arising from mesodermal embryonic remnants

Tadashi Terada

PATHOLOGY INTERNATIONAL (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.